Salarius Pharmaceuticals Inc (SLRX) Short-Term Debt to Equity
Salarius Pharmaceuticals (SLRX) automates the creation of antitumor agents, utilizing AI and robotics to reduce manual labor. The price trend reflected in this chart is accompanied by a critical capital shortage, which calls the business's survival into question due to previous FDA delays. The company currently relies on grants while awaiting profits from the implementation of targeted therapy, with the metric standing at 0.00.
%3A%20Short-Term%20Debt%20to%20Capital%20Ratio&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_SLRX_-_Salarius-Pharmaceuticals_-_Short-Term-Debt-to-Capital-Ratio "Salarius - SLRX Short-Term Debt to Capital (period 07/04/2022 - 01/08/2026) | 👁️GURU.Markets👁️")
Financial and market metric breakdowns for salariuspharma.com (SLRX)
- stock quotes and analyst forecast:
- market capitalization details:
- balance sheet equity data:
- business debt structure and liquidity details:
Debt to Equity Salarius Pharmaceuticals|SLRX - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio Salarius Pharmaceuticals, Inc.|SLRX - Aggregate Debt Obligations|Debts to Book Capitalization Salarius Pharmaceuticals Inc|SLRX - Company Long-Term Liabilities|Company Current Liabilities Salarius Pharmaceuticals|Quick Liquidity salariuspharma.com
- earnings and market ratios statistics:
Fundamental valuation:Salarius
Developing innovative epigenetic cancer therapies, Salarius Pharmaceuticals (SLRX) relies on patents, while the current level of short-term capital load reflects the proportion of liabilities with a maturity of over one year to equity, allowing investors to assess financial stability and default risk when scaling developments without sacrificing commercial margins.
Competitors of Salarius Pharmaceuticals
Short-Term Debt to Capital ONC|Short-Term Debt to Capital Halozyme Corp (HALO)|Short-Term Debt to Equity Revolution Medicines RVMD|AAPG: Short-Term Debt to Capital Ratio|CG Oncology - Short-Term Debt to Capital|UroGen Pharma Ltd (URGN) - Short-Term Debt to Equity Ratio|BCAX: Short-Term Debt to Capital|Current Liabilities to Capital Personalis Genomics (PSNL)|Short-Term Debt to Equity Erasca, Inc.|DCTH: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio YMAB (Y-mAbs Therapeutics, Inc.)|AURA (Aura Biosciences Inc) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital CADL (Candel Therapeutics, Inc.)|ARAY - Short-Term Debt to Equity Ratio|SLS: Short-Term Debt to Equity Ratio|ACTU - Short-Term Debt to Capital|Citius Oncology (CTOR) - Short-Term Debt to Equity|TuHURA Biosciences - Ratio of Short-Term Indebtedness to Capital|TARA (Protara) - Short-Term Debt to Capital|Current Liabilities to Capital Fate Pharma FATE|Short-Term Debt to Equity Aadi Bioscience Inc (WHWK)|Short-Term Debt to Capital Coefficient tscan.com|Short-Term Debt to Capital CSBR (Champions Oncology, Inc.)|Short-Term Debt to Capital XBiotech Inc XBIT|CVM - Short-Term Debt to Equity|OSTX: Short-Term Debt to Equity|RADX: Short-Term Debt to Capital|Artiva Biotherapeutics (ARTV) - Short-Term Debt to Capital|Short-Term Debt to Equity Adlai Nortye Ltd|VERU: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital TPST|Short-Term Debt to Capital Coefficient xiliotx.com|Renovaro - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Mural Oncology PLC MURA|KAPA - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient OnKure Therapeutics Inc OKUR|GDTC (w2.cytomed.sg) - Short-Term Debt to Equity Ratio|Curis - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Apollomics Inc.|tharimmune.com - Current Liabilities to Equity|Short-Term Debt to Capital ADVB|GNPX (Genprex Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital CLDI (Calidi Biotherapeutics, Inc.)|Short-Term Debt to Capital sunshinebiopharma.com SBFM|XBIO - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital PPBT (purple-biotech.com)|aoncology.com (AONC) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio BeiGene Ltd.|CKPT (Checkpoint Therapeutics, Inc) - Short-Term Debt to Capital|Short-Term Debt to Capital Elevation Oncology Inc.|Short-Term Debt to Capital ICAD|Short-Term Debt to Equity Ratio ikenaoncology.com IKNA|Short-Term Debt to Capital NTBL (Notable Labs)|Viracta Therapeutics Inc. (VIRX) - Current Liabilities to Capital|MOR: Short-Term Debt to Equity Ratio|NAYA - Short-Term Debt to Capital|AAPGV (Ascentage Pharma Group) - Short-Term Debt to Equity Ratio